-
-
-
-
-
-
-
Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
Verve Therapeutics to Participate in Upcoming Investor Conferences
-
-
-
-
-
-
-
Verve Therapeutics (VERV) Announces Proposed $200M Share Offering
-
-
-
-
-
-
-
Verve Therapeutics (VERV) IPO Prices at $19
-
22,828 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

